In this exclusive Discover Pharma interview, Sarah Tucker, Chief Operating Officer at Phastar, shares how the CRO is transforming clinical trials through flexible, data-driven delivery and patient-centric innovation. From decentralized models to Lean Six Sigma, she offers key insights into balancing speed with scientific rigor in today’s evolving trial landscape.
”As specialists in biometrics and data science, we don’t just support clinical trials — we optimize them. Our people, processes, and systems are purpose-built for precision, quality, and pace. We’re not generalists; our teams focus exclusively on biometrics, allowing us to apply deep expertise and statistical rigor to every project.”